BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

EGALET CORPORATION

via BGR GOVERNMENT AFFAIRS

3rd Quarter (July 1 - Sep 30) · 2016Posted Oct 20, 2016Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: EGALET CORPORATION
Description: Pharmaceutical company
Location: Pennsylvania · United States of America

Registrant

Firm: BGR GOVERNMENT AFFAIRS
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Federal legislation pertaining to prescription drug abuse/utilization of abuse deterrent technology
Lobbyistsmr DAVID BOYER · RYAN LONG · BRENT ALAN DEL MONTE
Covered position (mr DAVID BOYER): See prior filing
Covered position (RYAN LONG): See prior filing
Covered position (BRENT ALAN DEL MONTE): See prior filing
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

EGALET CORPORATION — Lobbying — Receipts Report